UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and validation of an HPLC–MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run

Biomedical chromatography, 2021-12, Vol.35 (12), p.e5224-n/a

2021

Volltextzugriff (PDF)

Validation of an analytical method using HPLC–MS/MS to quantify osimertinib in human plasma and supplementary stability results

Biomedical chromatography, 2020-04, Vol.34 (4), p.e4771-n/a

2020

Volltextzugriff (PDF)

Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation

Therapeutic drug monitoring, 2017-08, Vol.39 (4), p.412-421

2017

Volltextzugriff (PDF)

Vancomycin dosing in neutropenic patients

PloS one, 2014-11, Vol.9 (11), p.e112008-e112008

2014

Volltextzugriff (PDF)

Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineage

BMC microbiology, 2009-10, Vol.9 (1), p.229-229, Article 229

2009

Volltextzugriff (PDF)

Development and validation of an analytical method using UPLC–MS/MS to quantify everolimus in dried blood spots in the oncology setting

Journal of pharmaceutical and biomedical analysis, 2018-02, Vol.149, p.106-113

2018

Volltextzugriff (PDF)

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

Breast cancer research and treatment, 2021-07, Vol.188 (2), p.571-581

2021

Volltextzugriff (PDF)

Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib

JTO clinical and research reports, 2023-05, Vol.4 (5), p.100513-100513, Article 100513

2023

Volltextzugriff (PDF)

Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

JTO clinical and research reports, 2024-04, Vol.5 (4), p.100656-100656, Article 100656

2024

Volltextzugriff (PDF)

Unpredictable Effects of Rifampin as an Adjunctive Agent in Elimination of Rifampin-Susceptible and -Resistant Staphylococcus aureus Strains Grown in Biofilms

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3907-3912

2010

Volltextzugriff (PDF)

Comment on “Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case–control study from Denmark”

Journal of the American Academy of Dermatology, 2021-12, Vol.85 (6), p.e357-e357

2021

Volltextzugriff (PDF)

Drug–drug interactions with tyrosine-kinase inhibitors

The lancet oncology, 2014-09, Vol.15 (10), p.e416-e416

2014

Volltextzugriff (PDF)

Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin B

Journal of antimicrobial chemotherapy, 2021-03, Vol.76 (4), p.961-966

2021

Volltextzugriff (PDF)

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer

British journal of cancer, 2024-08, Vol.131 (3), p.481-490

2024

Volltextzugriff (PDF)

Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2023-12, Vol.1231, p.123918-123918, Article 123918

2023

Volltextzugriff (PDF)

Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels

Therapeutic drug monitoring, 2016-02, Vol.38 (1), p.120-126

2016

Volltextzugriff (PDF)

Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer: The OSIBOOST trial

Lung cancer (Amsterdam, Netherlands), 2022-09, Vol.171, p.97-102

2022

Volltextzugriff (PDF)

Development and validation of a fast and sensitive UHPLC-DAD assay for the quantification of nitrofurantoin in plasma and urine

Journal of pharmaceutical and biomedical analysis, 2019-09, Vol.174, p.161-167

2019

Volltextzugriff (PDF)

Toxicity of pemetrexed during renal impairment explained—Implications for safe treatment

International journal of cancer, 2021-10, Vol.149 (8), p.1576-1584

2021

Volltextzugriff (PDF)

Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer

International journal of cancer, 2024-01, Vol.154 (2), p.332-342

2024

Volltextzugriff (PDF)

Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors

Cancer epidemiology, 2022-06, Vol.78, p.102149-102149, Article 102149

2022

Volltextzugriff (PDF)

Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters

Biomaterials, 2011-02, Vol.32 (5), p.1264-1269

2011

Volltextzugriff (PDF)

Systematic Evaluation of Osimertinib Population Pharmacokinetic Models in a Cohort of Dutch Adults with Non-Small Cell Lung Cancer

European journal of drug metabolism and pharmacokinetics, 2024-07, Vol.49 (4), p.517-526

2024

Volltextzugriff (PDF)

Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human Plasma

Therapeutic drug monitoring, 2020-02, Vol.42 (1), p.146-150

2020

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(36)
Humans
(29)
Oncology
(17)
Pharmacology & Pharmacy
(14)
Female
(10)
Pharmacokinetics
(10)
Male
(9)
Non-Small Cell Lung Cancer
(8)
Lung Cancer
(7)
Physical Sciences
(7)
Chemistry
(6)
Chemistry, Analytical
(6)
Lung Neoplasms - Drug Therapy
(6)
Original
(6)
Osimertinib
(6)
Patients
(6)
Reproducibility Of Results
(6)
Aged
(5)
Anti-Bacterial Agents - Pharmacokinetics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development and validation of an HPLC–MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run

Validation of an analytical method using HPLC–MS/MS to quantify osimertinib in human plasma and supplementary stability results

Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation

Vancomycin dosing in neutropenic patients

Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineage

Development and validation of an analytical method using UPLC–MS/MS to quantify everolimus in dried blood spots in the oncology setting

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib

Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

Unpredictable Effects of Rifampin as an Adjunctive Agent in Elimination of Rifampin-Susceptible and -Resistant Staphylococcus aureus Strains Grown in Biofilms

Comment on “Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case–control study from Denmark”

Drug–drug interactions with tyrosine-kinase inhibitors

Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin B

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer

Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs

Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels

Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer: The OSIBOOST trial

Development and validation of a fast and sensitive UHPLC-DAD assay for the quantification of nitrofurantoin in plasma and urine

Toxicity of pemetrexed during renal impairment explained—Implications for safe treatment

Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer

Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors

Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters

Systematic Evaluation of Osimertinib Population Pharmacokinetic Models in a Cohort of Dutch Adults with Non-Small Cell Lung Cancer

Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human Plasma

Suchergebnisse filtern